ENTITY
CSL Ltd

CSL Ltd (CSL AU)

227
Analysis
Health Care • Australia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
Exchange Announcement • 08 Oct 2026 15:44

Update on U.S. Plasma Collection Network

Exchange Announcement • 07 Oct 2026 06:24

CSL prices US$1.5 billion in Corporate Bonds

Exchange Announcement • 05 Oct 2026 05:22

CSL enters exclusive agreement with Alentis Therapeutics

Exchange Announcement • 24 Sep 2026 06:22

Update - Notification of buy-back - CSL

Exchange Announcement • 23 Sep 2026 06:17

Update - Notification of buy-back - CSL

x